ProKidney (PROK) has provided an announcement.
ProKidney Corp. has appointed Ulrich Ernst, Ph.D., as Executive Vice President, Technical Operations, bringing over three decades of biopharmaceutical expertise to the role. Dr. Ernst, who previously held senior positions at Iovance Biotherapeutics and Amunix Operating among others, will earn a base salary of $450,000 with the potential for a 40% bonus and an option award for 500,000 Class A shares, subject to vesting conditions. This strategic hire underscores ProKidney’s commitment to advancing their technical operations and reinforces their position in the competitive biotech industry.
Find detailed analytics on PROK stock on TipRanks’ Stock Analysis page.
